![Ed Feener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Edward P.
Feener is the founder of KalVista Pharmaceuticals Ltd., founded in 2011, serving as Chief Scientific Officer since 2011.
Dr. Feener is the founder of KalVista Pharmaceuticals, Inc., founded in 2004, serving as Chief Scientific Officer since 2016.
Dr. Feener was Associate Professor at Harvard Medical School from 1989 to 2016.
Dr. Feener earned a doctorate from Boston University in 1989.
Aktive Positionen von Ed Feener
| Unternehmen | Position | Beginn |
|---|---|---|
| KALVISTA PHARMA | Gründer | 26.03.2004 |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral medicines | Gründer | 01.01.2011 |
Ehemalige bekannte Positionen von Ed Feener
| Unternehmen | Position | Ende |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.10.2016 |
Ausbildung von Ed Feener
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KalVista Pharmaceuticals Ltd.
KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral medicines | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
